UTHR Sale Disclosure
Rothblatt Martine A · SEC Form 4 · Filed Nov 4, 2026
Sale
Calculated transaction value
$72.72K
Rothblatt Martine A Chairperson & CEO
UTHR
Transaction date
Nov 3, 2026
Public filing date
Nov 4, 2026
Filing lag
Filed 1 day later
UTHR daily price context
Close on/before transaction
$601.32
Nov 3, 2026
First close after public filing
$565.72
Nov 5, 2026
Return after filing · so far
-0.65%
Through Nov 6, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 120 shares @ $605.97
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001106578-26-000178
Filing cohort
Transactions in this filing
Showing 10 of 10
Trades
10
Issuers
1
Estimated value
$6.84M
Buys / sales
0 / 8
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| United Therapeutics Corp UTHR Current | Sale | Nov 3, 2026 | $72.72K |
| United Therapeutics Corp UTHR | Sale | Nov 3, 2026 | $507.91K |
| United Therapeutics Corp UTHR | Exercise | Nov 3, 2026 | $1.12M |
| United Therapeutics Corp UTHR | Sale | Nov 3, 2026 | $255.04K |
| United Therapeutics Corp UTHR | Sale | Nov 3, 2026 | $770.15K |
| United Therapeutics Corp UTHR | Sale | Nov 3, 2026 | $1.32M |
| United Therapeutics Corp UTHR | Sale | Nov 3, 2026 | $866.21K |
| United Therapeutics Corp UTHR | Sale | Nov 3, 2026 | $760.12K |
| United Therapeutics Corp UTHR | Sale | Nov 3, 2026 | $1.16M |
| United Therapeutics Corp UTHR | Exercise | Nov 3, 2026 | $0 |